首页> 外文期刊>Nature Genetics >Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
【24h】

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

机译:具有t(1; 14)(p22; q32)的MALT淋巴瘤的失活突变和BCL10(一种含半胱氨酸蛋白酶募集域的基因)的过表达。

获取原文
获取原文并翻译 | 示例
           

摘要

Mucosa-associated lymphoid tissue (MALT) lymphomas most frequently involve the gastrointestinal tract and are the most common subset of extranodal non-Hodgkin lymphoma (NHL). Here we describe overexpression of BCL10, a novel apoptotic signalling gene that encodes an amino-terminal caspase recruitment domain (CARD), in MALT lymphomas due to the recurrent t(1;14)(p22;q32). BCL10 cDNAs from t(1;14)-positive MALT tumours contained a variety of mutations, most resulting in truncations either in or carboxy terminal to the CARD. Wild-type BCL10 activated NF-kappaB but induced apoptosis of MCF7 and 293 cells. CARD-truncation mutants were unable to induce cell death or activate NF-kappaB, whereas mutants with C-terminal truncations retained NF-kappaB activation but did not induce apoptosis. Mutant BCL10 overexpression might have a twofold lymphomagenic effect: loss of BCL10 pro-apoptosis may confer a survival advantage to MALT B-cells, and constitutive NF-kappaB activation may provide both anti-apoptotic and proliferative signals mediated via its transcriptional targets.
机译:粘膜相关淋巴样组织(MALT)淋巴瘤最常累及胃肠道,是结外型非霍奇金淋巴瘤(NHL)的最常见亚型。在这里,我们描述了由于复发性t(1; 14)(p22; q32)在MALT淋巴瘤中过表达BCL10(一种新型的凋亡信号转导基因,编码一个氨基末端胱天蛋白酶募集域(CARD))的过表达。来自t(1; 14)阳性MALT肿瘤的BCL10 cDNA包含多种突变,大多数导致CARD末端或羧基末端的截短。野生型BCL10激活NF-κB,但诱导MCF7和293细胞凋亡。 CARD截短突变体无法诱导细胞死亡或激活NF-kappaB,而具有C端截短的突变体保留了NF-kappaB的激活但不诱导凋亡。突变的BCL10过表达可能具有双重淋巴瘤发生作用:BCL10促凋亡的丧失可能赋予MALT B细胞生存优势,而组成性NF-κB激活可能提供通过其转录靶点介导的抗凋亡和增殖信号。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号